Pediatric anesthesia & critical care

Preventing hypothermia in pediatric neurosurgery in Africa—A randomized controlled non‐inferiority trial of insulation versus active warming

Acta Anaesthesiol ScandPublished Randomised controlled trial

Authors' conclusion

Although perioperative core temperatures were not significantly different, we could not declare an inexpensive heat-preserving method non-inferior to warm air convection in preventing intraoperative hypothermia in children undergoing anesthesia for cranial neurosurgery in a resource-limited setting.

Study context

Population
Children younger than 12 years scheduled for cranial neurosurgery in a large East-African hospital (resource-limited setting)77 analysed
Participants
38 vs 39
Comparison
Hibler's method vs forced-air warming
  • Hibler'sn = 38
  • Warm airn = 39reference
Primary endpoint
Incidence of hypothermia (core temperature < 36.0° for longer than 5 min)
Methodological detailsnon-inferiority, block-randomized by age
  • Non-inferiority
  • Block-randomized by age

Primary result

As reported in the abstract

Hibler's vs Warm airOdds ratio (95% CI)P value
Hibler's
1.07(0.43–2.65)
P = 0.890

Non-inferiority margin 20 as printed, not drawn

Exceeded the 0.2 margin; non-inferiority could not be declared
risk difference 1.55% (95% CI −0.20 to −0.24)

Secondary outcomes

OutcomeHibler'sWarm airOR (95% CI)P value
Need for rescue measures71.1 0%69.2%1.09 (0.41–2.90)P = 0.861

Prespecified secondary outcomes (hypothermia duration as proportion of surgical duration, postoperative shivering, rescue measures)

No statistically significant difference between groups for any prespecified secondary outcome

Original publication

Preventing hypothermia in pediatric neurosurgery in Africa—A randomized controlled non‐inferiority trial of insulation versus active warming. Acta Anaesthesiol Scand. Published 26 October 2023. doi:10.1111/aas.14341

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.